1. 1504 Impact of worsening in patient reported symptomatic adverse events (AEs) on deterioration of daily assessed quality of life(QOL) in cancer patients receiving initial chemotherapy; prospective exploratory study. (September 2015) Authors: Horie, Y.; Mori, K.; Kyomori, C.; Izawa, N.; Taniyama, T.; Hirakawa, M.; Ogura, T.; Tsuda, T.; Nakajima, T.; Boku, N. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of antifouling compounds on the growth of macroalgae Undaria pinnatifida. (January 2023) Authors: Nomura, M.; Okamura, H.; Horie, Y.; Yap, C.K.; Emmanouil, C.; Uwai, S.; Kawai, H. Journal: Chemosphere Issue: Volume 312:Part 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long‐term safety of linagliptin monotherapy in Japanese patients with type 2 diabetes. Issue 4 (7th December 2012) Authors: Araki, E.; Kawamori, R.; Inagaki, N.; Watada, H.; Hayashi, N.; Horie, Y.; Sarashina, A.; Thiemann, S.; von Eynatten, M.; Dugi, K.; Woerle, H.‐J. Journal: Diabetes, obesity & metabolism Issue: Volume 15:Issue 4(2013:Apr.) Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Overall Health, Daily Functioning, and Quality of Life in Acute Hepatic Porphyria Patients: ENVISION, a Phase 3 Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. (February 2020) Authors: Sardh, E.; Gouya, L.; Rees, D.C.; Stein, P.; Stölzel, U.; Aguilera Peiro, P.; Bissell, D.M.; Bonkovsky, H.L.; Keel, S.; Parker, C.; Phillips, J.D.; Silver, S.; Windyga, J.; D'Avola, D.; Ross, G.; Stewart, P.; Ritchie, B.; Oh, J.; Harper, P.; Wang, J.D. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. STAT6 and IL‐10 are required for the anti‐arthritic effects of Schistosoma mansoni via different mechanisms. (15th October 2018) Authors: Osada, Y.; Horie, Y.; Nakae, S.; Sudo, K.; Kanazawa, T. Journal: Clinical and experimental immunology Issue: Volume 195:Number 1(2019) Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗